SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-24-005552
Filing Date
2024-09-18
Accepted
2024-09-18 16:30:48
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11561
  Complete submission text file 0000902664-24-005552.txt   13574
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Issuer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 718-570-6018
Caligan Partners LP (Reporting) CIK: 0001727492 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34703 | Film No.: 241307943

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address
JOHNSON DAVID EDWARD (Reporting) CIK: 0001785557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34703 | Film No.: 241307942